Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients Academic Article uri icon

Overview

MeSH Major

  • Melanoma
  • Receptor Protein-Tyrosine Kinases
  • Skin Neoplasms

abstract

  • Relapses were most frequently patient-detected in all stage II substages, highlighting the importance of patient education and self-examination. The highest yield for routine imaging is in stage IIC patients during the first 4 years. Physician examination is unlikely to detect relapses beyond 3 years for stage IIA and IIB and beyond 2 years for stage IIC patients.

publication date

  • April 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5505631

Digital Object Identifier (DOI)

  • 10.1245/s10434-016-5642-0

PubMed ID

  • 27804026

Additional Document Info

start page

  • 939

end page

  • 946

volume

  • 24

number

  • 4